SOTERA HEALTH COMPANY Retained Earnings
SOTERA HEALTH COMPANY (SHC) had Retained Earnings of -$451.86 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$451.86M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$505.50M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$532.09M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$566.94M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$451.86M 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$505.50M 10-Q · filed 2026-05-05 |
| 2025-12-31 | -$532.09M 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$566.94M 10-Q · filed 2025-11-04 |
| 2025-06-30 | -$615.34M 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$623.30M 10-Q · filed 2025-05-01 |
| 2024-12-31 | -$610.04M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$622.37M 10-Q · filed 2024-11-05 |
| 2024-06-30 | -$639.36M 10-Q · filed 2024-08-05 |
| 2024-03-31 | -$648.12M 10-Q · filed 2024-05-02 |
| 2023-12-31 | -$654.44M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$693.12M 10-Q · filed 2023-11-01 |
| 2023-06-30 | -$679.46M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$702.97M 10-Q · filed 2023-05-03 |
| 2022-12-31 | -$705.82M 10-K · filed 2024-02-27 |
| 2022-09-30 | -$386.10M 10-Q · filed 2022-11-02 |
| 2022-06-30 | -$411.19M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$441.61M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$472.25M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$508.24M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$535.69M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$578.29M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$589.13M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |